- Home
- CPRX vs GNW Comparison
CPRX vs GNW Comparison
Compare CPRX & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- GNW
- Stock Information
- Founded
- CPRX 2002
- GNW 1871
- Country
- CPRX United States
- GNW United States
- Employees
- CPRX N/A
- GNW N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- GNW Life Insurance
- Sector
- CPRX Health Care
- GNW Finance
- Exchange
- CPRX Nasdaq
- GNW Nasdaq
- Market Cap
- CPRX 2.9B
- GNW 3.3B
- IPO Year
- CPRX 2006
- GNW 2004
- Fundamental
- Price
- CPRX $21.81
- GNW $7.32
- Analyst Decision
- CPRX Strong Buy
- GNW Buy
- Analyst Count
- CPRX 6
- GNW 1
- Target Price
- CPRX $32.83
- GNW $9.50
- AVG Volume (30 Days)
- CPRX 1.4M
- GNW 7.6M
- Earning Date
- CPRX 08-06-2025
- GNW 07-30-2025
- Dividend Yield
- CPRX N/A
- GNW N/A
- EPS Growth
- CPRX 178.13
- GNW 141.92
- EPS
- CPRX 1.57
- GNW 0.49
- Revenue
- CPRX $534,645,999.00
- GNW $7,217,000,000.00
- Revenue This Year
- CPRX $16.37
- GNW N/A
- Revenue Next Year
- CPRX $8.80
- GNW N/A
- P/E Ratio
- CPRX $13.93
- GNW $14.11
- Revenue Growth
- CPRX 29.97
- GNW N/A
- 52 Week Low
- CPRX $15.34
- GNW $5.99
- 52 Week High
- CPRX $26.58
- GNW $8.08
- Technical
- Relative Strength Index (RSI)
- CPRX 42.36
- GNW 45.22
- Support Level
- CPRX $20.62
- GNW $7.79
- Resistance Level
- CPRX $22.06
- GNW $8.08
- Average True Range (ATR)
- CPRX 0.66
- GNW 0.18
- MACD
- CPRX 0.03
- GNW -0.07
- Stochastic Oscillator
- CPRX 56.67
- GNW 6.85
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.